Risk of diabetic ketoacidosis of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials

Background: Sodium–glucose cotransporter-2 (SGLT2) inhibitors have proven to be effective in improving glycemic control in patients with type 2 diabetes mellitus (T2DM). However, the risk of diabetic ketoacidosis (DKA) in patients remains unclear. The purpose of this study is to conduct this systema...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shiwen, Liu, Ying, Zhang, Shengzhao, Wu, Fengbo, Liu, Dan, Wu, Qingfang, Zheng, Hanrui, Fan, Ping, Su, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311413/
https://www.ncbi.nlm.nih.gov/pubmed/37397500
http://dx.doi.org/10.3389/fphar.2023.1145587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311413/
https://www.ncbi.nlm.nih.gov/pubmed/37397500
http://dx.doi.org/10.3389/fphar.2023.1145587

Ejemplares similares